Autism Spectrum Disorder Trial, Recruiting NCT05987761 Sponsor: Stanford University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05987761
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Autism Spectrum Disorder (ASD) and are considered higher functioning or low support needs
  • Your IQ score is above 80, based on a specific intelligence test called the WASI-II
  • You are right-handed
  • You do not have any metal in or on your body that cannot be removed (such as braces)
  • Your first language is English
  • You live in the San Francisco Bay Area
  • You are able and willing to attend weekly sessions for 9 weeks
  • The adolescent participating is interested in improving their social skills
  • You are able to safely have an MRI scan (no major reasons preventing this)
  • Your ASD diagnosis has been confirmed using specific assessment tools called the ADOS-2 and ADI-R
  • Your autism is not linked to a genetic, metabolic, or infectious cause (confirm with trial site)
  • ASD is your primary diagnosis
  • There were no significant complications during pregnancy, birth, or the newborn period
  • Any current treatments, therapies, medications, or school placements have been stable for at least 1 month before the study starts, with no planned changes during the study
  • You score at or below 50% in at least 4 out of 9 social skill areas on a specific assessment given before the study begins

Who may not be able to join:

  • You have a history of claustrophobia (fear of enclosed spaces), a previous head injury, a serious neurological or medical illness, a birth weight under 4 pounds, or were born before 34 weeks of pregnancy
  • You are left-handed
  • You have braces or any metal in or on your body that cannot be removed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

(Target) Change from baseline (Pre-training) in brain connectivity between superior temporal sulcus (STS) and the nucleus accumbens (NAc); Change from baseline (Pre-training) in structured laboratory observations (SLO) of child-assessor interactions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov